Northeast Pharmaceutical Group Co., Ltd.

Shenzhen Stock Exchange 000597.SZ

Northeast Pharmaceutical Group Co., Ltd. Free Cash Flow Yield on January 27, 2025: 5.03%

Northeast Pharmaceutical Group Co., Ltd. Free Cash Flow Yield is 5.03% on January 27, 2025, a -3.88% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Northeast Pharmaceutical Group Co., Ltd. 52-week high Free Cash Flow Yield is 6.64% on July 24, 2024, which is 31.87% above the current Free Cash Flow Yield.
Northeast Pharmaceutical Group Co., Ltd. 52-week low Free Cash Flow Yield is 4.03% on November 07, 2024, which is -19.97% below the current Free Cash Flow Yield.
Northeast Pharmaceutical Group Co., Ltd. average Free Cash Flow Yield for the last 52 weeks is 5.41%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

Shenzhen Stock Exchange: 000597.SZ

Northeast Pharmaceutical Group Co., Ltd.

CEO	Mr. Zhou Kai
IPO Date	May 23, 1996
Location	China
Headquarters	No.8 Kunminghu Street
Employees	6,214
Sector	Healthcare
Industries Pharmaceuticals Chemicals & Advanced Materials Cleaning Supplies Fertilizers Non-Alcoholic Beverages Personal Care Petrochemicals Plastics

Description

Northeast Pharmaceutical Group Co., Ltd. provides chemical synthetic and bio-fermentation APIs, and medicinal and micro-ecological preparation products in China. It offers various nutritional products, such as Vitamin C, L-Carnitine, and other products; API products comprising fosfomycin, anti-aids, and other products; and chemical products, including chemical and pharmaceutical intermediates, chiral separation reagent products, etc. The company also provides digestives, narcotic medicines, cardiovascular, cerebrovascular medicines, etc. In addition, it engages in medical distribution business. Northeast Pharmaceutical Group Co., Ltd. was founded in 1993 and is based in Shenyang, China.

Key trends

Past 5 years